Form 012 ADHD Assessment and Treatment Process
Effective 3 March 2025
ADHD Assessment Process
The fee for an ADHD assessment is $1,200 less Medicare rebates of $386.75 making a total out of pocket cost of $813.25.
An ADHD assessment would require at least two meetings with a psychiatrist at the clinic.
We will send you some scales and questionnaires to complete prior to your first appointment and it is expected to be returned at least a week before to your appointment.
The first appointment will take about one hour. If you have any school reports available, please bring them. We encourage reading your school reports in advance and prepare to show teachers comments suggestive of ADHD or other difficulties. We understand that some people have no access to their school reports, and it should not affect your assessment.
Collateral information is required for a diagnosis, and we encourage you to bring a family member or someone who knows you well. We understand that in some cases it might be difficult or not possible. Please let us know and we can try to arrange an alternative way to obtain a collateral information (for example a phone call outside of your meeting with a doctor).
Second appointment – Discussing your diagnosis, management plan, and starting treatment if treatment is indicated.
Urine drug test is a mandatory requirement before starting ADHD medication (stimulants) and can be completed at CliniPath following a referral from our psychiatrist.
If treatment with ADHD medication is indicated but cardio-vascular risk factors are identified, our psychiatrist might need to organise a referral for an ECG (electrocardiogram) or referral to a specialist. Some patients may require further medical input (GP, cardiologist or other specialists) before starting treatment with ADHD medication.
Follow up Appointments:
After stimulant treatment commencement, regular follow-up appointments would be required. The frequency of appointments varies depending on your presentation and complexity. most common schedule is a first review three months after treatment initiation, and then 6 monthly.